News

World's first primary standard developed for molecular radiotherapy

The new primary standard for MRT
The new primary standard for MRT – Courtesy of NPL

Researchers from EMRP project develop the world's first primary standard for molecular radiotherapy (MRT) to treat cancer

The new standard will help improve the consistency of MRT treatments, in which radioactive molecules, or radiopharmaceuticals, are injected directly into a patient's body to target and kill cancerous cells. Such standardisation is vital to encourage more widespread use of MRT and develop new and improved radiopharmaceuticals.

Like any form of radiotherapy, the success of MRT relies on the delivery of an extremely precise dose of radiation. The goal is to maximise the dose delivered to the tumour, while minimising damage to surrounding healthy tissue. However, in contrast to other forms of radiotherapy, dosimetry for MRT is not well established. Researchers from EMRP project Metrology for molecular radiotherapy (HLT11 MetroMRT) developed the new standard.  A gas-filled ionisation chamber, containing two parallel electrodes an adjustable distance apart, enables the user to measure the absorbed radiation dose from a radioactive solution.

Select your area of interest
EMPIR Call 2017: Stage 2 Now Open
2017-06-14

EURAMET announces the launch of the Stage 2 EMPIR Call 2017 more

World Accreditation Day 2017
2017-06-09

Delivering confidence in construction and the built environment more

Ensuring fire safety in new buildings
2017-06-09

Statistical methods for conformity assessment when dealing with computationally expensive systems: application to a fire engineering case study more

3D models to assess plant safety
2017-06-09

New process to prove correctness of calculations with complex, numerical algorithms implemented in measurement software developed by EMRP project NEW0... more

Page 1 of 93.